Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis

Abstract Dysfunction of immunoinhibitory signals and persistent T cell activation reportedly play important roles in the development of vasculitis. The skin is one of the most accessible organs, and it is suitable for the characterization of immune cell signatures. However, the inhibitory checkpoint...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chie Miyabe, Yupeng Dong, Takaharu Ikeda, Kazuo Takahashi, Yoshishige Miyabe, Tamihiro Kawakami
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d62971d8fd3544cbac7a12184d4cb702
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d62971d8fd3544cbac7a12184d4cb702
record_format dspace
spelling oai:doaj.org-article:d62971d8fd3544cbac7a12184d4cb7022021-12-02T18:07:52ZImmune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis10.1038/s41598-021-99558-52045-2322https://doaj.org/article/d62971d8fd3544cbac7a12184d4cb7022021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99558-5https://doaj.org/toc/2045-2322Abstract Dysfunction of immunoinhibitory signals and persistent T cell activation reportedly play important roles in the development of vasculitis. The skin is one of the most accessible organs, and it is suitable for the characterization of immune cell signatures. However, the inhibitory checkpoint molecules in the skin and their relevance to vasculitis have not been studied. Here, we investigated the profile of immune checkpoint molecules in the skin and peripheral blood of patients with vasculitis and healthy donors. We found that some of the inhibitory checkpoint molecules, including programmed cell death 1 receptor (PD-1), were elevated in T-cells in the blood of patients with systemic and cutaneous vasculitis. In addition, programmed death-ligand 1 (PD-L1) expression was elevated in the skin of patients with cutaneous vasculitis. Histologically, PD-L1 was highly expressed in the vessels in the skin along with CD4+ and CD8+ T-cell infiltration in patients with cutaneous vasculitis. Notably, plasma soluble PD-L1 levels were increased, and these correlated with C-reactive protein in patients with systemic vasculitis. Our findings suggest that inhibitory checkpoint molecules might be differentially modulated in the skin and peripheral blood of patients with vasculitis, and that the alteration of the PD-L1/PD-1 axis may be associated with the regulation of T-cell activation in vasculitis.Chie MiyabeYupeng DongTakaharu IkedaKazuo TakahashiYoshishige MiyabeTamihiro KawakamiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Chie Miyabe
Yupeng Dong
Takaharu Ikeda
Kazuo Takahashi
Yoshishige Miyabe
Tamihiro Kawakami
Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
description Abstract Dysfunction of immunoinhibitory signals and persistent T cell activation reportedly play important roles in the development of vasculitis. The skin is one of the most accessible organs, and it is suitable for the characterization of immune cell signatures. However, the inhibitory checkpoint molecules in the skin and their relevance to vasculitis have not been studied. Here, we investigated the profile of immune checkpoint molecules in the skin and peripheral blood of patients with vasculitis and healthy donors. We found that some of the inhibitory checkpoint molecules, including programmed cell death 1 receptor (PD-1), were elevated in T-cells in the blood of patients with systemic and cutaneous vasculitis. In addition, programmed death-ligand 1 (PD-L1) expression was elevated in the skin of patients with cutaneous vasculitis. Histologically, PD-L1 was highly expressed in the vessels in the skin along with CD4+ and CD8+ T-cell infiltration in patients with cutaneous vasculitis. Notably, plasma soluble PD-L1 levels were increased, and these correlated with C-reactive protein in patients with systemic vasculitis. Our findings suggest that inhibitory checkpoint molecules might be differentially modulated in the skin and peripheral blood of patients with vasculitis, and that the alteration of the PD-L1/PD-1 axis may be associated with the regulation of T-cell activation in vasculitis.
format article
author Chie Miyabe
Yupeng Dong
Takaharu Ikeda
Kazuo Takahashi
Yoshishige Miyabe
Tamihiro Kawakami
author_facet Chie Miyabe
Yupeng Dong
Takaharu Ikeda
Kazuo Takahashi
Yoshishige Miyabe
Tamihiro Kawakami
author_sort Chie Miyabe
title Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
title_short Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
title_full Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
title_fullStr Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
title_full_unstemmed Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
title_sort immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d62971d8fd3544cbac7a12184d4cb702
work_keys_str_mv AT chiemiyabe immunecheckpointmoleculeexpressionisalteredintheskinandperipheralbloodinvasculitis
AT yupengdong immunecheckpointmoleculeexpressionisalteredintheskinandperipheralbloodinvasculitis
AT takaharuikeda immunecheckpointmoleculeexpressionisalteredintheskinandperipheralbloodinvasculitis
AT kazuotakahashi immunecheckpointmoleculeexpressionisalteredintheskinandperipheralbloodinvasculitis
AT yoshishigemiyabe immunecheckpointmoleculeexpressionisalteredintheskinandperipheralbloodinvasculitis
AT tamihirokawakami immunecheckpointmoleculeexpressionisalteredintheskinandperipheralbloodinvasculitis
_version_ 1718378659563175936